Literature DB >> 23897482

The structure of full-length human CTNNBL1 reveals a distinct member of the armadillo-repeat protein family.

Xiaolan Huang1, Guan Wang, Yuhong Wu, Zhihua Du.   

Abstract

Catenin-β-like protein 1 (CTNNBL1) is a highly conserved protein with multiple functions, one of which is to act as an interaction partner of the antibody-diversification enzyme activation-induced cytidine deaminase (AID) for its nuclear import and subnuclear trafficking. Here, the crystal structure of full-length human CTNNBL1 is reported. The protein contains six armadillo (ARM) repeats that pack into a superhelical ARM domain. This ARM domain is unique within the ARM protein family owing to the presence of several unusual structural features. Moreover, CTNNBL1 contains significant and novel non-ARM structures flanking both ends of the central ARM domain. A strong continuous hydrophobic core runs through the whole structure, indicating that the ARM and non-ARM structures fold together to form an integral structure. This structure defines a highly restrictive and discriminatory protein-binding groove that is not observed in other ARM proteins. The presence of a cluster of histidine residues in the groove implies a pH-sensitive histidine-mediated mechanism that may regulate protein binding activity. The many unique structural features of CTNNBL1 establish it as a distinct member of the ARM protein family. The structure provides critical insights into the molecular interactions between CTNNBL1 and its protein partners, especially AID.

Entities:  

Keywords:  AID; CTNNBL1; armadillo repeat; nuclear import

Mesh:

Substances:

Year:  2013        PMID: 23897482     DOI: 10.1107/S0907444913011360

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  7 in total

1.  Metazoan evolution of the armadillo repeat superfamily.

Authors:  Ismail Sahin Gul; Paco Hulpiau; Yvan Saeys; Frans van Roy
Journal:  Cell Mol Life Sci       Date:  2016-08-06       Impact factor: 9.261

2.  Expression, purification and crystallization of the SKICH domain of human TAX1BP1.

Authors:  Yang Yang; Guan Wang; Xiaolan Huang; Zhihua Du
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-04-15       Impact factor: 1.056

3.  Disease-associated CTNNBL1 mutation impairs somatic hypermutation by decreasing nuclear AID.

Authors:  Marcel Kuhny; Lisa R Forbes; Elif Çakan; Andrea Vega-Loza; Valentyna Kostiuk; Ravi K Dinesh; Salomé Glauzy; Asbjorg Stray-Pedersen; Ashley E Pezzi; I Celine Hanson; Alexander Vargas-Hernandez; Mina LuQuing Xu; Zeynep H Coban-Akdemir; Shalini N Jhangiani; Donna M Muzny; Richard A Gibbs; James R Lupski; Ivan K Chinn; David G Schatz; Jordan S Orange; Eric Meffre
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

4.  CTNNBL1 facilitates the association of CWC15 with CDC5L and is required to maintain the abundance of the Prp19 spliceosomal complex.

Authors:  Febe van Maldegem; Sarah Maslen; Christopher M Johnson; Anita Chandra; Karuna Ganesh; Mark Skehel; Cristina Rada
Journal:  Nucleic Acids Res       Date:  2015-06-29       Impact factor: 16.971

5.  Small angle X-ray scattering studies of CTNNBL1 dimerization and CTNNBL1/CDC5L complex.

Authors:  Jae-Woo Ahn; Kyeong Sik Jin; Hyeoncheol Francis Son; Jeong Ho Chang; Kyung-Jin Kim
Journal:  Sci Rep       Date:  2015-09-18       Impact factor: 4.379

6.  Structural and mutational analysis reveals that CTNNBL1 binds NLSs in a manner distinct from that of its closest armadillo-relative, karyopherin α.

Authors:  Karuna Ganesh; Febe van Maldegem; Stephanie B Telerman; Paul Simpson; Christopher M Johnson; Roger L Williams; Michael S Neuberger; Cristina Rada
Journal:  FEBS Lett       Date:  2013-11-20       Impact factor: 4.124

7.  An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses.

Authors:  Xue F Huang; Si-Yi Chen; Guan Wang; Xi Kang; Katherine S Chen; Tiffany Jehng; Lindsey Jones; Jie Chen
Journal:  Nat Commun       Date:  2020-03-13       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.